Remdesivir
Also Known As: Remdesivir, Veklury
Remdesivir, sold under the brand name Veklury,[1] is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences.[2] It is administered via injection into a vein.[3][4] As of 2020, remdesivir is being tested as a specific treatment for COVID-19, and has been authorized for emergency use in the US, India,[5] Singapore,[6] and approved for use in Japan for people with severe symptoms.[1][7][8][1][9] It also received approval in the UK in May 2020, however, it was going to be rationed due to limited supply.[10] It may shorten the time it takes to recover from the infection.[11]
Print this Page